These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 565382)

  • 21. Activation of the alternative pathway of complement by human peripheral nerve myelin.
    Koski CL; Vanguri P; Shin ML
    J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway.
    Suankratay C; Zhang XH; Zhang Y; Lint TF; Gewurz H
    J Immunol; 1998 Mar; 160(6):3006-13. PubMed ID: 9510205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
    Melamed J; Medicus RG; Arnaout MA; Colten HR
    J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The complement system. Normal values and congenital deficiencies in the adult Mexican population].
    Becerra Posada C; Reyes PA
    Arch Inst Cardiol Mex; 1985; 55(3):243-6. PubMed ID: 2932077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple one-step hemolytic assay for C2 with C2-deficient human serum.
    Ngan BY; Gelfand EW; Minta JO
    J Immunol; 1977 Mar; 118(3):736-41. PubMed ID: 321681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing sera.
    Arnaout MA; Davis AE; Rosen RS; Alper CA
    J Immunol; 1977 Oct; 119(4):1316-20. PubMed ID: 894039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the alternative pathway of complement by pH.
    Fishelson Z; Horstmann RD; Müller-Eberhard HJ
    J Immunol; 1987 May; 138(10):3392-5. PubMed ID: 2952717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activation of complement by isolated human heart subcellular membranes.
    Giclas PC; Pinckard RN; Olson MS
    J Immunol; 1979 Jan; 122(1):146-51. PubMed ID: 762412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methods for assaying nine bovine complement components and C3b-inactivator.
    Linscott WD; Triglia RP
    Mol Immunol; 1980 Jun; 17(6):729-40. PubMed ID: 7432350
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective deficiency of the second component of complement in a patient with anaphylactoid purpura.
    Gelfand EW; Clarkson JE; Minta JO
    Clin Immunol Immunopathol; 1975 Jul; 4(2):269-76. PubMed ID: 1095265
    [No Abstract]   [Full Text] [Related]  

  • 35. Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway.
    Newman SL; Vogler LB; Feigin RD; Johnston RB
    N Engl J Med; 1978 Aug; 299(6):290-2. PubMed ID: 661928
    [No Abstract]   [Full Text] [Related]  

  • 36. Titers of nine complement components, conglutinin and C3b-inactivator in adult and fetal bovine sera.
    Triglia RP; Linscott WD
    Mol Immunol; 1980 Jun; 17(6):741-8. PubMed ID: 7432351
    [No Abstract]   [Full Text] [Related]  

  • 37. The human complement system.
    Volanakis JE
    J Oral Pathol; 1975; 4(4):195-221. PubMed ID: 811779
    [No Abstract]   [Full Text] [Related]  

  • 38. Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway.
    Kings M; Nydegger UE; de Weck AL
    Immunology; 1984 Jan; 51(1):123-31. PubMed ID: 6197357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 40. Defective activation of the alternative pathway of complement in patients with homozygous C2 deficiency: studies in two unrelated families.
    Schwertz R; Esser E; Seger RA; Rubinstein A; Hauptmann G; Wahn V
    Eur J Pediatr; 1991 Jul; 150(9):647-51. PubMed ID: 1915518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.